Related Experiment Video
Updated: Aug 6, 2026
Measuring the Effect of Chemicals on the Growth and Reproduction of Caenorhabditis elegans
Published on: October 5, 2017
Evaluating Caenorhabditis elegans as a Toxicity Model for Reuptake Inhibitors
Christopher E Hernandez1, Alexandra Van Stone2, Christopher So1
1College of Pharmacy, Roseman University of Health Sciences, Henderson, Nevada, United States.
Abstract:
Drug toxicity assessment is important for drug development. Here, we evaluated whether the invertebrate model Caenorhabditis elegans can be used to assess the toxicity of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Drug-induced non-responsiveness served as a functional measure of toxicity. Overall, responses did not consistently parallel those of mammals, although select trends were conserved. Escitalopram showed greater toxicity than citalopram, duloxetine was more toxic than milnacipran, and desvenlafaxine, but not venlafaxine, produced toxicity. These results suggest that C. elegans cannot replace mammalian testing, but may serve as a rapid and low-cost prescreening model.
Insights
The nematode worm, Caenorhabditis elegans, can prescreen selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) drug toxicity. However, C. elegans responses do not fully replicate mammalian outcomes, limiting its use as a replacement for animal testing.
Area of Science:
- Pharmacology
- Toxicology
- Model Organisms
Background:
- Drug toxicity evaluation is critical in pharmaceutical development.
- Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are widely prescribed antidepressants.
- Invertebrate models offer potential for rapid and cost-effective toxicity screening.
Purpose of the Study:
- To investigate the utility of Caenorhabditis elegans as a model for assessing the toxicity of SSRIs and SNRIs.
- To compare the toxicity profiles of select SSRIs and SNRIs in C. elegans with known mammalian responses.
Main Methods:
- Utilized C. elegans as an invertebrate model system.
- Assessed drug toxicity by measuring drug-induced non-responsiveness.
- Evaluated a panel of SSRIs and SNRIs for their toxic effects in C. elegans.
Main Results:
- C. elegans exhibited differential toxicity responses to SSRIs and SNRIs.
- Observed conserved trends in toxicity for some drugs, such as escitalopram > citalopram and duloxetine > milnacipran.
- Desvenlafaxine induced toxicity in C. elegans, whereas venlafaxine did not.
Conclusions:
- C. elegans demonstrates potential as a rapid, low-cost prescreening tool for SSRI and SNRI toxicity.
- The C. elegans model does not fully recapitulate mammalian toxicity profiles, indicating it cannot replace established mammalian testing.
- Further research may refine the use of C. elegans for early-stage drug safety assessment.
More Related Videos
09:01A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
Published on: March 14, 2019
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021